Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1990 Aug;100(4):774–778. doi: 10.1111/j.1476-5381.1990.tb14091.x

Effects of acute and chronic clozapine on dopamine release and metabolism in the striatum and nucleus accumbens of conscious rats.

R Invernizzi 1, F Morali 1, L Pozzi 1, R Samanin 1
PMCID: PMC1917584  PMID: 2207499

Abstract

1. The effect of single and repeated (once daily for 23 days) oral doses of 20 and 60 mg kg-1 clozapine on dopamine release and metabolism were studied by intracerebral dialysis in the striatum and nucleus accumbens of conscious rats. 2. The basal output of dopamine, dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in the striatum and nucleus accumbens of rats given clozapine 20 or 60 mg kg-1 chronically, measured one day after the last drug dose, was not significantly different from that of vehicle-treated animals. 3. Challenge doses of 20 or 60 mg kg-1 clozapine produced similar increases in dopamine levels in the striatum and nucleus accumbens of animals which had received vehicle or clozapine 20 or 60 mg kg-1 once daily for 23 days, except that 1 h after administration 60 mg kg-1 clozapine had a greater effect in the nucleus accumbens. 4. In animals treated chronically with clozapine 20 and 60 mg kg-1 or vehicle, DOPAC levels in the striatum and nucleus accumbens were increased to the same extent by challenge doses of clozapine (20 or 60 mg kg-1). In animals treated chronically with clozapine, a challenge dose of 60 mg kg-1 had significantly greater effect on HVA only in the nucleus accumbens. 5. When DOPAC and HVA were measured post mortem in the striatum and nucleus accumbens 2 h after various oral doses of clozapine, it was found that 10 mg kg-1 significantly increased dopamine metabolites only in the nucleus accumbens whereas 100 mg kg-1 had this effect in both regions.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
777

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andén N. E., Stock G. Effect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic system. J Pharm Pharmacol. 1973 Apr;25(4):346–348. doi: 10.1111/j.2042-7158.1973.tb10025.x. [DOI] [PubMed] [Google Scholar]
  2. Baldessarini R. J., Tarsy D. Mechanisms underlying tardive dyskinesia. Res Publ Assoc Res Nerv Ment Dis. 1976;55:433–446. [PubMed] [Google Scholar]
  3. Bartholini G. Differential effect of neuroleptic drugs on dopamine turnover in the extrapyramidal and limbic system. J Pharm Pharmacol. 1976 May;28(5):429–433. doi: 10.1111/j.2042-7158.1976.tb04648.x. [DOI] [PubMed] [Google Scholar]
  4. Beckmann B., Hippius H., Rüther E. Treatment of schizophrenia. Prog Neuropsychopharmacol. 1979;3(1-3):47–52. doi: 10.1016/0364-7722(79)90068-7. [DOI] [PubMed] [Google Scholar]
  5. Bettini E., Ceci A., Spinelli R., Samanin R. Neuroleptic-like effects of the l-isomer of fenfluramine on striatal dopamine release in freely moving rats. Biochem Pharmacol. 1987 Jul 15;36(14):2387–2391. doi: 10.1016/0006-2952(87)90608-3. [DOI] [PubMed] [Google Scholar]
  6. Bürki H. R., Ruch W., Asper H., Baggiolini M., Stille G. Effect of single and repeated administration of clozapine on the metabolism of dopamine and noradrenaline in the brain of the rat. Eur J Pharmacol. 1974 Jul;27(2):180–190. doi: 10.1016/0014-2999(74)90144-7. [DOI] [PubMed] [Google Scholar]
  7. Chiodo L. A., Bunney B. S. Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons. J Neurosci. 1985 Sep;5(9):2539–2544. doi: 10.1523/JNEUROSCI.05-09-02539.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chiodo L. A., Bunney B. S. Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J Neurosci. 1983 Aug;3(8):1607–1619. doi: 10.1523/JNEUROSCI.03-08-01607.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cotes P. M., Crow T. J., Johnstone E. C., Bartlett W., Bourne R. C. Neuroendocrine changes in acute schizophrenia as a function of clinical state and neuroleptic medication. Psychol Med. 1978 Nov;8(4):657–665. doi: 10.1017/s0033291700018869. [DOI] [PubMed] [Google Scholar]
  10. Gerlach J., Thorsen K., Fog R. Extrapyramidal reactions and amine metabolites in cerebrospinal fluid during haloperidol and clozapine treatment of schizophrenic patients. Psychopharmacologia. 1975;40(4):341–350. doi: 10.1007/BF00421473. [DOI] [PubMed] [Google Scholar]
  11. Glowinski J., Iversen L. L. Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J Neurochem. 1966 Aug;13(8):655–669. doi: 10.1111/j.1471-4159.1966.tb09873.x. [DOI] [PubMed] [Google Scholar]
  12. Grace A. A., Bunney B. S. Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: analysis using in vivo intracellular recording. J Pharmacol Exp Ther. 1986 Sep;238(3):1092–1100. [PubMed] [Google Scholar]
  13. Imperato A., Di Chiara G. Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis. J Neurosci. 1985 Feb;5(2):297–306. doi: 10.1523/JNEUROSCI.05-02-00297.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Imperato A., Di Chiara G. Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites. J Neurosci. 1984 Apr;4(4):966–977. doi: 10.1523/JNEUROSCI.04-04-00966.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ladinsky H., Consolo S., Samanin R., Algeri S., Ponzio F. Long-term effects of haloperidol, Clozapine, and methadone on rat striatal cholinergic and dopaminergic dynamics. Adv Biochem Psychopharmacol. 1980;24:259–265. [PubMed] [Google Scholar]
  16. Maidment N. T., Marsden C. A. Repeated atypical neuroleptic administration: effects on central dopamine metabolism monitored by in vivo voltammetry. Eur J Pharmacol. 1987 Apr 14;136(2):141–149. doi: 10.1016/0014-2999(87)90705-9. [DOI] [PubMed] [Google Scholar]
  17. O'Connor W. T., Drew K. L., Ungerstedt U. Differences in dopamine release and metabolism in rat striatal subregions following acute clozapine using in vivo microdialysis. Neurosci Lett. 1989 Mar 27;98(2):211–216. doi: 10.1016/0304-3940(89)90512-0. [DOI] [PubMed] [Google Scholar]
  18. Racagni G., Bruno F., Bugatti A., Parenti M., Apud J. A., Santini V., Carenzi A., Groppetti A., Cattabeni F. Behavioral and biochemical correlates after haloperidol and clozapine long-term treatment. Adv Biochem Psychopharmacol. 1980;24:45–51. [PubMed] [Google Scholar]
  19. Waldmeier P. C., Maître L. Clozapine: reduction of the initial dopamine turnover increase by repeated treatment. Eur J Pharmacol. 1976 Jul;38(1):197–203. doi: 10.1016/0014-2999(76)90219-3. [DOI] [PubMed] [Google Scholar]
  20. Waldmeier P. C., Maître L. On the relevance of preferential increases of mesolimbic versus striatal dopamine turnover for the prediction of antipsychotic activity of psychotropic drugs. J Neurochem. 1976 Aug;27(2):589–597. doi: 10.1111/j.1471-4159.1976.tb12287.x. [DOI] [PubMed] [Google Scholar]
  21. Westerink B. H., Korf J. Influence of drugs on striatal and limbic homovanillic acid concentration in the rat brain. Eur J Pharmacol. 1975 Aug;33(1):31–40. doi: 10.1016/0014-2999(75)90134-x. [DOI] [PubMed] [Google Scholar]
  22. White F. J., Wang R. Y. Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science. 1983 Sep 9;221(4615):1054–1057. doi: 10.1126/science.6136093. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES